Conformal Medical

This past week #NYVALVES2024 summit did not disappoint.    The support and excitement for the CLAAS® system did not go unnoticed. The dedication to advancing cardiovascular care resonates deeply, and we eagerly anticipate the far-reaching impact of these discussions within the medical community, propelling structural heart and LAAO technology, focusing on #Size, #Seal, and #Scale, with the innovative CLAAS device.   We look forward to the fall and connecting with industry leaders about the next-gen CLAAS system.   #CardiovascularInnovation #LAAtherapy #ConformalMedical #MedicalAdvancements #Cardiology #LAAO #data #conformalmedical #claas #Afib #NYVALVES2024 #electrophysiology #interventionalcardiology   CAUTION: Investigational Device The CLAAS System is limited by Federal (or United States) law to investigational use.

Get ready for an enriching experience at the #NYVALVES2024 Summit! Dive into a knowledge-packed week with sessions you can't miss. Discover advanced techniques and evidence-based practices through live-case demonstrations, hands-on training, debates, and the latest updates in the field. At Conformal Medical, our CLAAS® device aims to reduce the risk of stroke without the need for anticoagulants in patients with atrial fibrillation.  Meet with our team to learn about our next-gen device and our confirmed seal rate of 97.7% seal without significant (>3mm) leaks at 12 months, comparing favorably with marketed devices¹ from our Early Feasibility Study. See you there!  #CardiovascularInnovation #LAAtherapy #ConformalMedical #MedicalAdvancements #Cardiology #LAAO #data #conformalmedical #claas #Afib #NYVALVES2024 #electrophysiology #interventionalcardiology   1. Gray W, Conformal Early Feasibility Study: 12 Months Results. TCT 2023   CAUTION: Investigational Device The CLAAS System is limited by Federal (or United States) law to investigational use.

#NYVALVES2024 attendees, don't miss out! Grab a coffee and join Aaron Kaplan, MD., tomorrow morning, Wed, June 5th, for his presentation on Early Feasibility Studies: How to Enable Innovation While Maintaining Safety. It's going to be an informative and insightful session you won't want to miss! #CardiovascularInnovation #LAAtherapy #ConformalMedical #MedicalAdvancements #Cardiology #LAAO #data #conformalmedical #CLAAS #Afib #NYVALVES2024 #electrophysiology #interventionalcardiology

Meet with the Conformal team at #NYVALVES2024 summit this week to learn how we are developing the next generation LAAO technology that conforms to a range of anatomies, enabling clinicians to simplify the procedure with only 2 sizes, and confirm seal with angiography.   Conformal is, shaping the future of LAAC therapy.   #CardiovascularInnovation #LAAtherapy #ConformalMedical #MedicalAdvancements #Cardiology #LAAO #data #conformalmedical #claas #Afib #NYVALVES2024 #electrophysiology #interventionalcardiology   CAUTION: Investigational Device The CLAAS System is limited by Federal (or United States) law to investigational use.

New York Valves kicks off next week in New York. This summit is an excellent opportunity to learn and explore structural heart therapies including Left Atrial Appendage Closure (LAAC)   Join the Conformal team at this premier conference in structural heart medicine and learn about the latest updates with CONFORM Trial and the next-gen CLAAS® System.   We look forward to seeing you at New York Valves, to learn more about the CONFORM Pivotal Trial and the CLAAS System, visit https://lnkd.in/exyWTx-x    #CardiovascularInnovation #LAAtherapy #ConformalMedical #MedicalAdvancements #Cardiology #LAAO #data #conformalmedical #claas #Afib #NYVALVES2024 #electrophysiology #interventionalcardiology   CAUTION: Investigational Device The CLAAS System is limited by Federal (or United States) law to investigational use.

It is estimated that 12.1 million people in the United States will have AFib in 2030.¹ ² Learn more about Conformal Medical and how we are developing the next generation of LAAO technology with the CLAAS® System. 1.    Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:199–225. 2.    Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112:1142–1147. doi: 10.1016/j.amjcard.2013.05.063. To learn about Conformal Medical click here: https://lnkd.in/exyWTx-x   #Cardiology #LAAO #conformalmedical #claas #Afib #CardioTech #ConformalMedical #interventionalcardiology #electrophysiology   CAUTION: Investigational Device The CLAAS System is limited by Federal (or United States) law to investigational use.

Congratulations to Dr. Ellis and the Team at Vanderbilt University Medical Center for successfully enrolling over 50 patients into the CONFORM Clinical Trial. His dedication to research and innovation continues to shape the future of cardiology, offering promising solutions for AF-related stroke prevention.   Christopher R. Ellis, MD, FACC, FHRS, is a Professor of Cardiovascular Medicine at Vanderbilt University Medical Center. He specializes in Atrial Fibrillation (AF) and stroke risk reduction strategies. He completed his medical training and fellowship at Vanderbilt, focusing on Left Atrial Appendage Closure (LAAC) and cardiac rhythm devices. Dr. Ellis has led groundbreaking research in LAAC and device management, contributing significantly to cardiovascular care. To learn more about the CONFORM Trial, visit the link. https://lnkd.in/e-3W_bZy   #Cardiology #LAAO #conformalmedical #claas #Afib #CardioTech #ConformalMedical #interventionalcardiology #electrophysiology   CAUTION: Investigational Device The CLAAS System is limited by Federal (or United States) law to investigational use.

With only two sizes, one of which treats nearly >90% of patients simplifying the imaging requirements, which has the potential to transform LAAO to a same day procedure, moving clinical practice away from general anesthesia and overnight hospitalizations.   Visit the Conformal website to learn more.  https://lnkd.in/eFTc4h7F #Cardiology #LAAO #data #conformalmedical #claas #Afib #CRT2024 #CardioTech #InnovationInTheHeartOfDC #ConformalMedica #interventionalcardiology #electrophysiology   CAUTION: Investigational Device The CLAAS System is limited by Federal (or United States) law to investigational use.

Today, we honor Melissa Farina, a true powerhouse in the finance world with over 20 years of leadership experience in the medical device industry. Her journey exemplifies the incredible impact women have in traditionally male-dominated fields.   Melissa's remarkable career includes various leadership roles in both public and private companies. Her resilience, determination, and expertise have propelled her success and paved the way for innovation and progress in the industry.   As the Chief Financial Officer at Conformal Medical, Melissa continues to make strides, driving awareness, building strategy, and focusing on financial strength to grow and elevate the company. Her dedication and vision inspire us to break barriers and excel in our chosen paths.   Let's celebrate Melissa and all the trailblazing women who are making history daily! #Cardiology #LAAO #data #conformalmedical #claas #Afib #interventionalcardiology #electrophysiology #WomenWhoLead #TrailblazingWomen #Conformalmedical

The CONFORMAL Early Feasibility Study (EFS) data one-year results demonstrated durable closure for LAAO indicated patients with 97.7% seal without significant (>3 mm) leaks at 12 months, comparing favorably with marketed devices.¹ The EFS data also confirmed an impressive 97% sizing correlation between TEE and angiography, to quickly confirm CLAAS device sizing.²   1. Gray W, Conformal Early Feasibility Study: 12 Months Results. Presented at TCT 2023 2. Gray W, Real-Time Atrial Appendage Assessment for LAAO-CLAAS Device Selection: Angiography vs TEE. Presented at CRT 2023   Visit the Conformal website to learn more about the CLAAS System. https://lnkd.in/d6XdifY2 Visit the Conformal website to learn more. https://lnkd.in/eFTc4h7F #Cardiology #LAAO #data #conformalmedical #claas #Afib #CRT2024 #CardioTech #InnovationInTheHeartOfDC #ConformalMedica #interventionalcardiology #electrophysiology   CAUTION: Investigational Device The CLAAS System is limited by Federal (or United States) law to investigational use.